Current Trends in Radiologic Management of Malignant Pleural Mesothelioma

Seminars in Thoracic and Cardiovascular Surgery

Volumn 21, Issue 2, 2009, Pages 111-120

  Gill, Ritu R ^a   Gerbaudo, Victor H ^a   Sugarbaker, David J ^a   Hatabu, Hiroto ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

imaging of MPM; mesothelioma; MPM; pleural malignancy

Indexed keywords

CARBOPLATIN; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; IODINATED CONTRAST MEDIUM; PEMETREXED;

ARTICLE; BENIGN TUMOR; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIAPHRAGM; DIFFUSION WEIGHTED IMAGING; HUMAN; LYMPH NODE METASTASIS; MALIGNANT MESOTHELIOMA; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PERITONEUM METASTASIS; PLEURA MESOTHELIOMA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RADIATION EXPOSURE; RADIODIAGNOSIS; RADIOLOGIST; THORAX WALL; TREATMENT RESPONSE; TUMOR VASCULARIZATION; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MESOTHELIOMA; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PALLIATIVE CARE; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; THORACIC SURGICAL PROCEDURES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 70349753193     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2009.06.011     Document Type: Article

References (30)

1. Kawashima A., and Libshitz H.I. Malignant pleural mesothelioma: CT manifestations in 50 cases. AJR Am J Roentgenol 155 (1990) 965-969
2. Metintas M., Ucgun I., Elbek O., et al. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol 41 (2002) 1-9
3. Patz Jr. E.F., Shaffer K., Piwnica-Worms D.R., et al. Malignant pleural mesothelioma: Value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol 159 (1992) 961-966
4. Wang Z.J., Reddy G.P., Gotway M.B., et al. Malignant pleural mesothelioma: Evaluation with CT, MR imaging, and PET. Radiographics 24 (2004) 105-119
5. Drevs J., and Schneider V. The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumour agents targeting angiogenesis. J Intern Med 260 (2006) 517-529
6. Armato III S.G., Oxnard G.R., MacMahon H., et al. Measurement of mesothelioma on thoracic CT scans: A comparison of manual and computer-assisted techniques. Med Phys 31 (2004) 1105-1115
7. Armato III S.G., Oxnard G.R., Kocherginsky M., et al. Evaluation of semiautomated measurements of mesothelioma tumor thickness on CT scans. Acad Radiol 12 (2005) 1301-1309
8. Armato III S.G., Ogarek J.L., Starkey A., et al. Variability in mesothelioma tumor response classification. AJR Am J Roentgenol 186 (2006) 1000-1006
9. Pass H.I., Temeck B.K., Kranda K., et al. Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 115 (1998) 310-317, discussion, 317-318
10. Heilo A., Stenwig A.E., and Solheim O.P. Malignant pleural mesothelioma: US-guided histologic core-needle biopsy. Radiology 211 (1999) 657-659
11. Heelan R.T., Rusch V.W., Begg C.B., et al. Staging of malignant pleural mesothelioma: Comparison of CT and MR imaging. AJR Am J Roentgenol 172 (1999) 1039-1047
12. Hatabu H., Tadamura E., Levin D.L., et al. Quantitative assessment of pulmonary perfusion with dynamic contrast-enhanced MRI. Magn Reson Med 42 (1999) 1033-1038
13. Hatabu H., Gaa J., Kim D., et al. Pulmonary perfusion: Qualitative assessment with dynamic contrast-enhanced MRI using ultra-short TE and inversion recovery turbo FLASH. Magn Reson Med 36 (1996) 503-508
14. Giesel F.L., Choyke P.L., Mehndiratta A., et al. Pharmacokinetic analysis of malignant pleural mesothelioma-initial results of tumor microcirculation and its correlation to microvessel density (CD-34). Acad Radiol 15 (2008) 563-570
15. Gill R.R., Gerbaudo V.H., Jacobson F.L., et al. MR imaging of benign and malignant pleural disease. MRI Clin North Am 16 (2008) 319-339 :x
16. Yamamuro M., Gerbaudo V.H., Gill R.R., et al. Morphologic and functional imaging of malignant pleural mesothelioma. Eur J Radiol 64 (2007) 356-366
17. Gerbaudo V.H., Sugarbaker D.J., Britz-Cunningham S., et al. Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: Comparison with histopathology. J Nucl Med 43 (2002) 1144-1149
18. Benard F., Sterman D., Smith R.J., et al. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest 114 (1998) 713-722
19. Gerbaudo V.H., Britz-Cunningham S., Sugarbaker D.J., et al. Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma. Thorax 58 (2003) 1077-1082
20. Beyer T., Townsend D.W., Brun T., et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 41 (2000) 1369-1379
21. Lardinois D., Weder W., Hany T.F., et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348 (2003) 2500-2507
22. Mamede M., Abreu E.L.P., Oliva M.R., et al. FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: Correlation with histopathology results. Am J Clin Oncol 30 (2007) 377-388
23. Gerbaudo V.H., and Julius B. Anatomo-metabolic characteristics of atelectasis in F-18 FDG-PET/CT imaging. Eur J Radiol 64 (2007) 401-405
24. Britz-Cunningham S.H., Millstine J.W., and Gerbaudo V.H. Improved discrimination of benign and malignant lesions on FDG PET/CT, using comparative activity ratios to brain, basal ganglia, or cerebellum. Clin Nucl Med 33 (2008) 681-687
25. Erasmus J.J., Truong M.T., Smythe W.R., et al. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications. J Thorac Cardiovasc Surg 129 (2005) 1364-1370
26. Shen K.R., Wain J.C., Wright C.D., et al. Postpneumonectomy syndrome: Surgical management and long-term results. J Thorac Cardiovasc Surg 135 (2008) 1210-1216, discussion, 1216-1219
27. Gerbaudo V., Mamede M., Trottman-Dickinson B., et al. PET/CT patterns of treatment failure of malignant pleural mesothelioma. [abstract]. J Nucl Med 48 (2007) 360
28. Flores R.M., Akhurst T., Gonen M., et al. Positron emission tomography predicts survival in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 132 (2006) 763-768
29. Giesel F.L., Bischoff H., Von Tengg-Kobligk H., et al. Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: A feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome. Chest 129 (2006) 1570-1576
30. Ceresoli G.L., Chiti A., Zucali P.A., et al. Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose. J Clin Oncol 24 (2006) 4587-4593